WL
William R Larue
Director

William R Larue insider trades: Tracon Pharmaceuticals (TCON) stock buys and sales

Director, Tracon Pharmaceuticals Last trade Dec 21, 2022 43 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2011
5
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 21, 2022TCON↓ Sell$151
Jul 26, 2021TCON↑ Buy$25K
Jun 2, 2017TCON↓ Sell$7K
Dec 17, 2013CADX↓ Sell$78K
Nov 18, 2013CADX↓ Sell$263K
Jul 17, 2013CADX↓ Sell$65K
Jun 27, 2013CADX↓ Sell$65K
Nov 21, 2011CADX↓ Sell$42K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About William R Larue's insider trades

William R Larue is a director at Tracon Pharmaceuticals (TCON). Since Nov 21, 2011, William has reported 1 open-market purchase worth $25K and 7 sales worth $519K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (33 filings), option exercises (5 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TCON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.